Incannex Healthcare (IXHL) Asset Utilization Ratio (2025)
Incannex Healthcare (IXHL) posted quarterly Asset Utilization Ratio of 0.0 for Q2 2025.
Incannex Healthcare (IXHL) Asset Utilization Ratio (2025) Analysis & Trends
Incannex Healthcare (IXHL) has reported Asset Utilization Ratio for 1 consecutive years, with 0.0 the latest figure, recorded in Q2 2025.
- Quarterly Asset Utilization Ratio changed N/A year-over-year to 0.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was 0.0 (changed N/A YoY) and the FY2025 annual result came in at 0.0, up 680.43% from the prior year.
- Asset Utilization Ratio was little changed at 0.0 in Q2 2025 per IXHL's latest filing.
- Over the last five years, Asset Utilization Ratio for IXHL reached as high as 0.0 in Q2 2025 and fell as low as 0.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.43 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.62 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.46 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.43 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.39 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.65 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.37 |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 0.00 |